Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.

HPS3/TIMI55–REVEAL Collaborative Group, Bowman L, Hopewell JC, Chen F, Wallendszus K, Stevens W, Collins R, Wiviott SD, Cannon CP, Braunwald E, Sammons E, Landray MJ

Open source

DOI
10.1056/nejmoa1706444
Published
2017 Sep 28
Container
The New England journal of medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa1706444,
  title = {Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.},
  author = {HPS3/TIMI55–REVEAL Collaborative Group and Bowman L and Hopewell JC and Chen F and Wallendszus K and Stevens W and Collins R and Wiviott SD and Cannon CP and Braunwald E and Sammons E and Landray MJ},
  year = {2017},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa1706444},
  url = {https://doi.org/10.1056/nejmoa1706444}
}

RIS

TY  - JOUR
TI  - Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.
AU  - HPS3/TIMI55–REVEAL Collaborative Group
AU  - Bowman L
AU  - Hopewell JC
AU  - Chen F
AU  - Wallendszus K
AU  - Stevens W
AU  - Collins R
AU  - Wiviott SD
AU  - Cannon CP
AU  - Braunwald E
AU  - Sammons E
AU  - Landray MJ
PY  - 2017
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa1706444
UR  - https://doi.org/10.1056/nejmoa1706444
ER  - 

APA

Group, H. C., L, B., JC, H., F, C., K, W., W, S., R, C., SD, W., CP, C., E, B., E, S., & MJ, L. (2017). Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.. The New England journal of medicine. https://doi.org/10.1056/nejmoa1706444

Source records